ORASURE TECHNOLOGIES, INC Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period
ORASURE TECHNOLOGIES, INC (OSUR) reported Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period of 2.00 thousand shares for the 3-month period ending 2016-03-31, per its 10-Q filed 2016-05-10.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod · last filed 2016-05-10
- ORASURE TECHNOLOGIES, INC share-based compensation arrangement by share-based payment award, equity instruments other than options, forfeited in period for the quarter ending 2016-03-31 was 2.00K shares, a 77.78% decline year-over-year.
- ORASURE TECHNOLOGIES, INC share-based compensation arrangement by share-based payment award, equity instruments other than options, forfeited in period for the quarter ending 2015-03-31 was 9.00K shares, a 43.75% decline year-over-year.
- ORASURE TECHNOLOGIES, INC share-based compensation arrangement by share-based payment award, equity instruments other than options, forfeited in period for the quarter ending 2014-03-31 was 16.00K shares.
- ORASURE TECHNOLOGIES, INC share-based compensation arrangement by share-based payment award, equity instruments other than options, forfeited in period for fiscal 2015 was 18.00K shares, a 25.00% decline from fiscal 2014.
- ORASURE TECHNOLOGIES, INC share-based compensation arrangement by share-based payment award, equity instruments other than options, forfeited in period for fiscal 2014 was 24.00K shares, a 60.00% decline from fiscal 2013.
- ORASURE TECHNOLOGIES, INC share-based compensation arrangement by share-based payment award, equity instruments other than options, forfeited in period for fiscal 2013 was 60.00K shares, a 328.57% increase from fiscal 2012.
- ORASURE TECHNOLOGIES, INC share-based compensation arrangement by share-based payment award, equity instruments other than options, forfeited in period for fiscal 2012 was 14.00K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period 12 month |
|---|---|---|
| 2016-03-31 | 2.00K shares 10-Q · filed 2016-05-10 | |
| 2015-12-31 | 18.00K shares 10-K · filed 2016-03-14 | |
| 2015-03-31 | 9.00K shares 10-Q · filed 2015-05-08 | |
| 2014-12-31 | 24.00K shares 10-K · filed 2016-03-14 | |
| 2014-03-31 | 16.00K shares 10-Q · filed 2014-05-08 | |
| 2013-12-31 | 60.00K shares 10-K · filed 2016-03-14 | |
| 2012-12-31 | 14.00K shares 10-K · filed 2015-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |